Associate Director/Lead International HTA Strategy - Oncology (all genders)

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Advances in scientific and technological research are opening new, promising treatments for previously difficult to treat diseases, increasing the demand on already constrained healthcare budgets. The challenging economic and political environment is leading Health Technology Assessment (HTA) agencies and payers to demand better outcomes at lower cost to the overall health system.  

In 2021, the European Commission adopted the EU HTA regulation with the key objective of accelerating patient access to innovative treatments by harmonizing methodologies, establishing predictability and avoiding duplications. For AbbVie, this provides a unique opportunity to demonstrate the value attributes of our assets & strengthen affiliate position in country Pricing & Reimbursement (P&R) appraisals. Joint Clinical Assessment (JCA) is the key component of the EU HTA regulation and comprises the EU HTA dossier that will need to be submitted to the Member State Coordination Group on HTA, in which the evidence of relative effectiveness and relative safety is summarized within a single submission. For AbbVie, JCA will enable better planning of market access strategies across Europe, driving the perception of value, removing redundancies with repetitive dossiers, saving time and ultimately resulting in smoother P&R negotiations, aiming to achieve faster and broader access for patients.

To succeed in this environment, we (AbbVie) need to fully understand market value drivers, identify the evidence required for Pricing, Reimbursement and Access (PRA), and work with the evidence generating functions to ensure that evidence generated will support successful JCA and HTA outcome along with PRA negotiations.  

The International HTA Strategy team was established to realize the full value of our assets by strategically informing drug development, evidence generation and HTA submissions, aligned with HTA/payer needs. The primary goals of the function are to ensure HTA evidence requirements are considered early in the development of AbbVie assets and implement a robust and aligned HTA strategy including EU HTA across the organization for the successful launch of Abbvie assets. The International HTA Strategy team oversees EU HTA Regulation implementation for AbbVie and leads Joint Scientific Consultation (JSC) and JCA strategy development and execution.

AbbVie is currently looking for an Associate Director/Lead within the International HTA Strategy team to support the EU HTA process for our new oncology assets
 

• Develop HTA insights collaborating with key affiliates to understand Access Evidence requirements for specific diseases and assets in oncology/hematology
• Support early affiliate engagement (early Touchpoint process) on behalf of International Market Access and Pricing (IMAP) to help inform (registrational) clinical development programs. This includes early Large Business Units (LBUs) PICOs development.
• Consult HTA reimbursement databases, develop HTA / payer engagement plans and gather insights from early scientific advice from HTA agencies and other external experts
• Internal stakeholders include IMAP; Global Health Economics and Outcomes Research; Affiliates; Areas; R&D; Commercial; Medical and Regulatory; Governance bodies
• Support the development of global payer evidence deliverables, working in close collaboration with global colleagues and external vendors
• Lead the strategy development and execution of JCA dossier for the oncology assets
• Lead external advocacy plan working with patient groups and external experts to shape the JCA strategy
• Lead the preparation of Market Access Analysis Plan (MAAP) and post hoc analysis plan
• Support areas/affiliates on local HTA submissions by providing strategic guidance and coordinating across evidence generation functions at global level (Medical Affairs, HEOR and Clinical Development) to answer questions from HTA agencies
• Support establishing the new framework and capabilities needed for successful EU HTA Regulation implementation
• Develop and execute contingency / risk mitigation planning

• The candidate must have at least 10 years of experience, preferably in a variety of international market access/HTA related areas (including market access, managed care marketing, health economics, HTA, clinical development, biostatistics, or medical affairs)
• Bachelor’s degree with a preference for candidates with an advanced degree in health economics, life sciences, health services, or related discipline (MSc, PhD)
• An understanding of pricing and reimbursement processes for at least one key HTA market 
• Understanding of health economics and evidence synthesis concepts
• Experience working within Oncology area is a plus
• Skilled in developing strategies to secure positive recommendations from influential HTA bodies
• Experience in developing HTA and reimbursement submissions 
• Experience with AMNOG, HAS, NICE, CDA dossier submissions is a plus
• Experience and strong ability in working collaboratively across matrix functions
• Strong project management capability with adherence to strict timelines
• Skilled in translating complex concepts into simple language 
• Experience of identifying and addressing evidence gaps

Key Behaviors

• Inspires and motivates others toward a shared purpose
• Influences colleagues to achieve cross-functional alignment
• Deals comfortably with risk and ambiguity, changing course when needed
• Makes timely, high-quality decisions with less than perfect information
• Sets clear strategies and robust implementation plans
• Has ability to understand complex problems and translate into simple ideas and solutions
• Acts respectfully yet courageously; says what needs to be said
• Communicates openly and honestly with all colleagues
• Connects unrelated concepts, generates original or unique ideas

Persistent and resilient — finds the way to move good ideas forward


 

What we offer you:

• Be part of a vibrant, diverse workplace where your ideas truly make a difference.
• Thrive in our open, collaborative culture that values every voice.
• Enjoy a competitive salary designed to reward your talents and contributions.
• Experience a personalized onboarding journey with dedicated mentorship, setting you up for success from day one.
• Benefit from flexible work models that empower a healthy work-life balance.
• Unlock access to extensive wellbeing resources, including health and fitness programs tailored to you.
• Take advantage of generous social benefits that support you beyond your career.
• Propel your career forward with endless growth opportunities in a global organization.
• Accelerate your development through elite training, learning, and advancement programs.
• Build connections that span the globe and join a powerful international network.

AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community.  Equal Opportunity Employer/Veterans/Disabled. 

US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html

US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:

https://www.abbvie.com/join-us/reasonable-accommodations.html